NUS Price To Sales Ratio from 2010 to 2024

NUS Stock  USD 7.22  0.08  1.10%   
Nu Skin Price To Sales Ratio yearly trend continues to be comparatively stable with very little volatility. Price To Sales Ratio will likely drop to 0.47 in 2024. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Nu Skin's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
0.49026074
Current Value
0.47
Quarterly Volatility
0.51757303
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nu Skin's main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 26.4 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0844 or PTB Ratio of 1.12. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.
  
Check out the analysis of Nu Skin Correlation against competitors.

Latest Nu Skin's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Nu Skin Enterprises over the last few years. Price to Sales Ratio is figured by comparing Nu Skin Enterprises stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Nu Skin sales, a figure that is much harder to manipulate than other Nu Skin Enterprises multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Nu Skin's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.20 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

NUS Price To Sales Ratio Regression Statistics

Arithmetic Mean1.19
Geometric Mean1.09
Coefficient Of Variation43.57
Mean Deviation0.37
Median1.03
Standard Deviation0.52
Sample Variance0.27
Range2.08
R-Value(0.60)
Mean Square Error0.18
R-Squared0.36
Significance0.02
Slope(0.07)
Total Sum of Squares3.75

NUS Price To Sales Ratio History

2024 0.47
2023 0.49
2022 0.95
2020 1.11
2019 0.94
2018 1.26

About Nu Skin Financial Statements

Nu Skin shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Nu Skin investors may analyze each financial statement separately, they are all interrelated. The changes in Nu Skin's assets and liabilities, for example, are also reflected in the revenues and expenses on on Nu Skin's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Price To Sales Ratio 0.49  0.47 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.